Release Date: June 8, 2012
U.S. Food and Drug Administration (FDA)
The purpose of this Notice is to correct contact information in the letter of intent section and the Financial/Grants Management contact.
Now Reads:
Letter of Intent |
The letter of intent should be emailed to: Yemisi Akinneye |
Should Read:
Letter of Intent |
The letter of intent should be sent by email to: Wendy Campbell, Project Officer |
Now Reads:
Financial/Grants Management Contact(s) |
Yemisi Akinneye |
Should Read:
Financial/Grants Management Contact(s) |
Dan Lukash |
All other aspects of the FOA remain unchanged.
Please direct all inquiries to:
Dan Lukash
Grants Management Specialist
U.S. Food and Drug Administration
Office of Acquisition and Grants Services
5630 Fishers Lane Room 1071
Rockville, MD 20857
TEL: 301-827-6771
FAX: 301-827-1044
EMAIL: daniel.lukash@fda.hhs.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
Office of Extramural Research (OER) |
|
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
|
Department of Health and Human Services (HHS) |
|
||||
|
NIH . . . Turning Discovery Into Health
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |
||||||||||